University of Montana
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Montana sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).
University of Montana: 24 sponsored US clinical trials, 8 recruiting.
University of Montana sponsors 24 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 13 completed. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Vestibular Hypofunction, with 2 trials.
Top-decile sponsor footprint
University of Montana ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
13 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
24 total, page 1 of 1
Evaluating the Feasibility and Reliability of Using Handheld Nebulizers to Conduct Cough Sensitivity Testing With Citric Acid
NCT07531901
The Food for Health Study
NCT07254689
PT for Montana Children With NMD Using Hippotherapy and the Equine Environment
NCT06887647
Understanding the Role of Doulas in Supporting People With PMADs
NCT05763537
Group Telehealth Behavioral Cough Suppression Therapy
NCT06706765
Improving Psychological and Vestibular Health: MINDGAPS
NCT05986279
Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty
NCT05720507
Making INformed Decisions in Gaze and Postural Stability: A Pilot Feasibility Study
NCT05391932
Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults
NCT07539987
Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough
NCT06960759
Developing and Evaluating an Indoor Air Pollution Intervention Among Cardiovascular Patients: the AIRWISE Study
NCT06384625
Internet-Behavioral Cough Suppression Therapy
NCT05770401
Circadian Rhythm Disruption Effects on Smoke Inhalation
NCT04955431
A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder
NCT04824521
Cough Desensitization Therapy: Pilot 2
NCT05226299
Cough Desensitization Therapy for Cough Hypersensitivity Syndrome
NCT04256733
Effects of Nature Exposure on Smoking Behavior
NCT03716440
Wood Smoke Interventions in Native American Populations
NCT02240069
Wood Stove Interventions and Child Respiratory Health
NCT02240134
Optimizing Plyometric Training for Functional Recovery Post-ACL Reconstruction
NCT02148172
Drug Combination on Exercise Performance at High Altitude
NCT01902758
Exposure, Relaxation, & Rescripting Therapy-Child
NCT02184026
Emerging Physical Therapy Practice in Palliative Care: A Survey of Perceptions of Physical Therapists
NCT01336361
Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation
NCT00670904
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
What is open in the University of Montana pipeline
8 recruiting of 24 indexed (33% open); 13 completed (54%).
Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Vestibular Hypofunction (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Montana: open-pipeline peers nationwide
Peers matched on 24 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
University of Montana sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 24 trials (± recruiting share)
- Acrotech Biopharma · 24 trials · 8% recruiting
- Agenus · 24 trials · 0% recruiting
- Akebia Therapeutics · 24 trials · 4% recruiting
- Blueprint Medicines Corporation · 24 trials · 25% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this University of Montana page
24 registered trials is a research-attention snapshot, not an endorsement of University of Montana or any single study.
- 8 of University of Montana's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Vestibular Hypofunction is the condition University of Montana studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vestibular Hypofunction trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Montana pipeline card: 24 registered trials from official public datasets.Report a data error.